Furthermore, several researchers have reported the role of anti-TNF-α agents in the development of different serious side effects, including infections, malignancies, autoimmune diseases, in particular systemic lupus erythematosus, Guillain–Barre syndrome and multiple sclerosis [78,79,80]. Here, TNF is linked to systemic lupus erythematosus.